Find Academic Supervisors

• Obstetrics
• Gynecology
• Maternal-Fetal Medicine
• +3 more

Line Rode serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, based at Rigshospitalet (Copenhagen University Hospital) in Copenhagen, Denmark. Her clinical and research activities are centered on advancing maternal-fetal health through evidence-based obstetric practice and epidemiological research. Dr. Rode's research program focuses on critical areas of obstetrics and gynecology, particularly pregnancy complications including migraine disorders, pre-eclampsia, preterm birth, and viral infections during gestation. Her work integrates clinical epidemiology with biomarker discovery to develop early screening tools and improve pregnancy outcomes. Key methodological approaches include systematic reviews, meta-analyses, and prospective cohort studies across diverse populations. Analysis of her 2024-2025 publications reveals a cohesive research trajectory in maternal-fetal medicine, with significant contributions to understanding migraine-pregnancy interactions, ART-related cardiometabolic outcomes, and trimester-specific SARS-CoV-2 effects. Her work spans both clinical obstetrics (pre-eclampsia screening, fetal membranes) and translational science (cardiac troponin assays), demonstrating interdisciplinary collaboration across cardiology, immunology, and reproductive medicine. Dr. Rode actively collaborates within Danish medical networks including the PRESIDE Study Group and multi-center initiatives like the COMPART cohort study. Her research outputs appear in high-impact journals such as Acta Obstetricia et Gynecologica Scandinavica , BMJ Open , and Ultrasound in Obstetrics and Gynecology , reflecting strong clinical relevance and methodological rigor in addressing contemporary challenges in women's health.

• Environmental Health
• Occupational Health
• Maternal and Child Health
• +2 more

Luise Mølenberg Begtrup serves as a Clinical Associate Professor in the Department of Public Health, Section of Environmental Health at the University of Copenhagen. Her research focuses on occupational and environmental health impacts during pregnancy, utilizing Denmark's comprehensive national registries for large-scale epidemiological studies. Her primary research areas include Environmental Health , Occupational Health , and Maternal-Child Epidemiology , with specific emphasis on physical workload, night shift work, and psychosocial stressors during pregnancy. She investigates how these exposures influence pregnancy outcomes, childhood development, and workforce participation through register-based cohort analyses. Recent publications (2024-2025) demonstrate consistent focus on developing exposure assessment tools like the PRECISE Job Exposure Matrix and analyzing the DOC*X-Generation cohort data. Key thematic areas include pregnancy-related work absence patterns, physical activity exposure during gestation, and sex-specific health outcomes in offspring. Dr. Begtrup actively contributes to major cohort initiatives including the PRECISE Occupational Cohort and DOC*X-Generation pregnancy cohort, which integrate detailed occupational exposure data with national health registries for comprehensive analysis of work-pregnancy interactions.

• Child and Adolescent Psychiatry
• Developmental Psychology
• Early Childhood Mental Health
• +3 more

Anne Lise Olsen serves as a Clinical Associate Professor in the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Based at Blegdamsvej 3, 2200 København N., Denmark, she specializes in Child and Adolescent Psychiatry with a clinical affiliation through Region Sjælland. Her research interests encompass critical areas of child development and mental health: Child and Adolescent Psychiatry Developmental Psychology Early Childhood Mental Health Schizophrenia Spectrum Disorders Regulatory Problems in Infancy Infant Development Dr. Olsen's recent publications demonstrate a consistent focus on how maternal mental health conditions impact infant development and outcomes. Her 2024 research examines both offspring of mothers with schizophrenia spectrum disorders and the longitudinal effects of regulatory problems in infancy. She employs both cross-sectional and systematic review methodologies, publishing in high-impact journals like Acta Psychiatrica Scandinavica and European Child and Adolescent Psychiatry. Though specific awards aren't documented in the available information, her publication record indicates recognition within the child psychiatry research community. Her work shows strong collaboration with Danish researchers across institutions, particularly in studies examining developmental trajectories and risk factors in early childhood mental health. Dr. Olsen's research contributes significantly to understanding early identification of at-risk children and informs potential intervention strategies during critical developmental periods, bridging clinical practice with population-based research approaches.

• Type 1 Diabetes
• Endocrinology
• Genetics
• +3 more

Flemming Pociot is a Clinical Professor at the University of Copenhagen, specifically within the Faculty of Health and Medical Sciences. He is affiliated with the Department of Clinical Medicine, where he specializes in Internal Medicine with a focus on Endocrinology. His primary research address is at Blegdamsvej 3, 2200 København N, Denmark, and he can be reached via email at flemming.pociot@regionh.dk. Professor Pociot's research primarily focuses on Type 1 Diabetes, with particular emphasis on understanding its genetic and immunological underpinnings. His work spans several key areas including diabetes pathogenesis, genetic risk factors, beta cell function preservation, and novel therapeutic approaches. He investigates how dietary patterns during pregnancy might influence diabetes risk in offspring, explores the heterogeneity of Type 1 Diabetes to develop more personalized treatment approaches, and examines the role of immune factors like TLR5 in diabetes development. His research often involves large-scale genetic studies and clinical trials aimed at preserving residual beta cell function in newly diagnosed patients. Analysis of Professor Pociot's recent publications reveals a strong focus on translational diabetes research that bridges basic science with clinical applications. His work demonstrates an increasing emphasis on personalized medicine approaches for Type 1 Diabetes, particularly through the development of risk prediction tools like the microRNA-based dynamic risk score. There's also a notable trend toward investigating environmental factors (such as diet) alongside genetic factors in diabetes pathogenesis. His research portfolio shows strong collaborative efforts across international boundaries, with numerous multi-center studies and involvement in expert consensus forums that shape the future direction of diabetes research and care. Professor Pociot has been actively involved in several significant research projects and clinical trials. His work on the effect of fenofibrate on residual beta cell function represents an important clinical investigation into preserving insulin production in newly diagnosed diabetes patients. He has also contributed to large-scale genetic studies examining risk variants across common diseases. His research has attracted attention across multiple platforms, with several publications being picked up by numerous news outlets and discussed across social media platforms including X (formerly Twitter), Facebook, and Bluesky.

Thomas HaafView profile

Professor

• Epigenetics
• Genome Reprogramming
• Congenital Hearing Impairments
• +8 more

Thomas Haaf is a University Professor (Professor) at the Institute of Human Genetics, University of Würzburg. He earned his MD (summa cum laude) from the University of Würzburg in 1985 and habilitation in 1989. After postdoctoral research at Stanford and Yale (1989-1995) and a research group leadership at the Max Planck Institute for Molecular Genetics (1995-2001), he held the chair of human genetics at Mainz University Hospital (2001-2009) before returning to Würzburg in 2009. Research Interests: Epigenetic genome reprogramming and its role in developmental origins of health and disease (DOHaD) Impact of assisted reproductive technologies (ART) on epigenetic stability in offspring Paternal age and obesity as epigenetic risk factors for intergenerational disease Genetic basis of congenital hearing impairments and monogenic disorders Epigenetic effects of maternal gestational diabetes on fetal metabolism Article Trends: His research spans epigenetics, reproductive biology, and developmental disorders. Recent work focuses on DNA methylation dynamics in ART, paternal factors, and imprinted gene regulation. Collaborations with families from Turkey, Iran, and Pakistan have advanced understanding of autosomal recessive hearing loss. Scientific Awards: Heisenberg Scholarship Science Prize of the German Society for Human Genetics Advising & Collaborations: He leads a research group at Würzburg and has mentored students like Dr. Ramya Potabattula and Laura Bernhardt. His work utilizes animal models (New World monkeys, cattle, mice) and cross-institutional partnerships.

Eduardo Albornoz BalmacedaView profile

Research Fellow

• Neuroinflammation
• Neurodegenerative Diseases
• Immunology
• +4 more

Dr. Eduardo Albornoz Balmaceda is a Research Fellow at the School of Biomedical Sciences , The University of Queensland , specializing in neuroinflammation and neurodegenerative diseases. He completed his PhD in 2019 under Prof Matthew Cooper at the Institute for Molecular Biosciences, focusing on NLRP3 inflammasome inhibitors for Parkinson's disease. Currently, he extends this research in the Woodruff Lab , investigating peripheral innate immune responses in amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease. Education: MSc in Biochemistry, Universidad Andrés Bello PhD in Neurosciences, The University of Queensland Research interests center on pharmacological targeting of inflammasomes and complement cascade components as therapeutic strategies for neuroinflammatory diseases. His work bridges neuroscience, immunology, and pharmacology, with a focus on SARS-CoV-2 neurotropism, microglial activation, and preclinical drug validation. Publications (17 journal articles, 8 conference papers) highlight his contributions to understanding C5a receptor signaling in Parkinson's disease, spike protein-mediated inflammasome activation in microglia, and maternal thyroid function's impact on offspring autoimmune responses. Supervision: Associate advisor for PhD on Huntington's disease Funding history includes grants from Motor Neurone Disease Research Institute of Australia and UniQuest Pty Ltd for projects like inflammatory biomarkers in Parkinson's disease and C9orf72 dipeptide targeting.

• Neurotoxicology
• Neuroteratology
• Developmental Neuroscience
• +4 more

Charles V. Vorhees is a Professor in the Department of Pediatrics at the University of Cincinnati College of Medicine, with primary research conducted at Cincinnati Children's Hospital. His laboratory focuses on developmental neurotoxicology and neuroteratology, investigating how early-life exposures to pharmaceuticals and environmental agents impact brain development and behavior. Dr. Vorhees' research spans multiple critical areas in neurotoxicology: Antidepressant Risks: Demonstrated that third-trimester-equivalent SSRI exposure causes learning deficits in rat offspring and serotonin reductions, with clinical correlations to increased Autism Spectrum Disorder risk Methamphetamine Neurotoxicity: Extensive work on how developmental methamphetamine exposure affects monoamine systems, spatial learning, and memory across different developmental periods Novel Assessment Methods: Developed improved approaches for developmental neurotoxicity testing that better align rodent models with human child outcomes His publication record shows consistent high-impact research since the 1970s, with recent work focusing on molecular mechanisms of neurotoxicity, including phosphodiesterase enzymes, tubulin mutations, and creatine metabolism. Dr. Vorhees maintains a long-standing collaboration with Dr. Michael T. Williams, with whom he has co-authored over 100 publications. Dr. Vorhees has contributed significantly to regulatory science through commentaries on developmental neurotoxicity testing standards, advocating for more comprehensive cognitive assessment in regulatory studies to better protect child health. His laboratory employs sophisticated behavioral paradigms including the Cincinnati Water Maze for egocentric navigation and Morris Water Maze for allocentric learning, with particular expertise in dissecting how developmental exposures alter specific cognitive domains rather than producing generalized deficits.

Susanne BrummelteView profile

Professor

• Developmental Neuroscience
• Neuroendocrinology
• Behavioral Neuroscience
• +6 more

Susanne Brummelte is a Professor in the Department of Psychology at Wayne State University, where she also serves as the Chair of the Behavioral and Cognitive Neuroscience Area. Her research is centered on developmental neuroscience, neuroendocrinology, and behavioral neuroscience, with a particular emphasis on the effects of early adverse life experiences on brain development and subsequent behavioral outcomes. Education: Postdoctoral Fellow, University of British Columbia and Child and Family Research Institute, Vancouver, BC, Canada (2007–2012) Dr. rer. nat (Ph.D. equivalent), Biology, University of Bielefeld, Germany (2007) Diplom (M.Sc. equivalent), Biology, University of Bielefeld, Germany (2004) Research Interests: Her lab investigates the consequences of exposure to depression, stress, or opioids during pregnancy or the postpartum period and how these factors affect brain neurochemistry and stress responsivity later in life. Using rats as the primary animal model, her team explores the impact of early pain exposure and medications such as antidepressants or treatments for opioid use disorder on brain development and maternal behavior. Research Collaborations: Dr. Brummelte collaborates with several researchers including Drs. Shane Perrine, Scott Bowen, Justin Kenney, Pat Mueller, Carolyn Herrington, Kelly Bosse, and Hilary Marusak. Recent Publications and Research Trends: Her recent work, supported by NIH grants, focuses on understanding the effects of opioid exposure during gestation on maternal and offspring outcomes. Her publications span topics from the impact of prenatal cannabis exposure on child brain connectivity to the role of maternal care in moderating the effects of gestational opioid exposure. Courses Taught: PSY7991 - Current Topics in Behavioral Neuroscience PSY8440 - Developmental Neuropsychology PSY3380 - Human Sexuality PSY3120 - Brain and Behavior Laboratory and Research Facilities: Her laboratory is equipped for behavioral testing, neuropharmacology, neuroendocrinology, immunohistochemistry, and ELISAs, enabling comprehensive investigations into the neurobiological mechanisms underlying early life adversity.

Shane PerrineView profile

Assistant Professor

• Neuropsychopharmacology
• Drug Addiction
• Co-occurring Psychiatric Conditions
• +5 more

Shane Perrine is an Assistant Professor in the Department of Psychiatry at Wayne State University School of Medicine. His research focuses on the neuropsychopharmacology of drug addiction and co-occurring psychiatric conditions, particularly depression and anxiety. Dr. Perrine's laboratory investigates how drugs, especially psychostimulants like cocaine, methamphetamine, and MDMA (ecstasy), affect neurochemistry and behavior. Using animal models, his work aims to elucidate the mechanisms of brain plasticity in response to acute and repeated drug exposure, stressors, and cues that lead to anxiety, depression, and relapse to drug seeking. His current research has two main directions: (1) determining the neurochemical underpinnings disrupted by psychostimulants that lead to anxiety, depression, and maladaptive reward behaviors; and (2) understanding the neurobiological basis underlying the comorbidity of PTSD and drug abuse. Dr. Perrine's recent publications reveal strong trends in neurobiological mechanisms of addiction with emphasis on sex differences, neuronal ensembles, and the intersection between PTSD and substance use disorders. His work frequently employs rodent models combined with behavioral testing, advanced neuroimaging, and molecular techniques. A significant portion examines how traumatic brain injury and stress exposure interact with substance use, including investigations into opioid exposure during pregnancy and its developmental consequences. Dr. Perrine teaches several courses including Molecular Neuropsychopharmacology (PYC7010), Neurobiology of Addiction (NEU4200), and Fundamentals of Neuroimaging (PYC7140). He collaborates with numerous researchers within Wayne State University and at other institutions including University of Arkansas, Emory University, University of Michigan, and Temple University. His laboratory employs methodologies including rodent models for reward, anxiety, and depression-related behaviors, western blotting, ELISA, HPLC, and proton-magnetic resonance spectroscopy. His primary disease/disorder focus is drug abuse and dependence, anxiety, and depression, with rats serving as the primary model species.

Vallo TilgarView profile

Associate Professor

• Animal Behavior
• Conservation Biology
• Ecology
• +6 more

Vallo Tilgar is an Associate Professor in the Department of Zoology at the University of Tartu, Estonia, affiliated with Peeter Hõrak's Lab. His research examines avian responses to environmental challenges, including noise pollution, dietary constraints, and habitat changes, with a focus on behavioral ecology, physiology, and conservation. Research Interests: Dr. Tilgar investigates how environmental stressors shape bird behavior and adaptation. Key areas include: Impact of anthropogenic noise on nesting and anti-predator behaviors Physiological mechanisms like serotonin pathways and corticosterone in reproduction Genomic variations in songbirds and gut microbiome dynamics Conservation strategies for farmland and urban bird populations Publication Trends: His recent articles (2017–2024) reveal a focus on: Avian stress responses to human-induced environmental changes Large-scale genomic and microbiome studies across European bird populations Behavioral plasticity in urban/rural habitats Integration of long-term ecological data via initiatives like SPI-Birds Lab & Affiliations: He conducts fieldwork and experiments through Peeter Hõrak's Lab, leveraging collaborations across Europe to address questions in evolutionary ecology and species resilience.

• Nutrition Science
• Obesity Research
• Prenatal Nutrition
• +4 more

Nina Rica Wium Geiker serves as a Guest Researcher at the Department of Nutrition, Exercise and Sports (NEXS) within the Faculty of Science at the University of Copenhagen. Her research is centered in the Lifecourse Nutrition & Health group, where she investigates critical intersections between nutrition, metabolism, and health outcomes across different life stages. Her research interests focus on prenatal nutrition interventions, particularly examining how maternal dietary patterns during pregnancy affect offspring growth trajectories and metabolic health. She has substantial expertise in body composition analysis, with numerous studies investigating adipose tissue distribution during pregnancy and its implications for maternal and child health outcomes. Her work frequently addresses obesity-related issues across the lifespan, from childhood interventions for socially vulnerable populations to metabolic consequences of fat distribution in adults. Dr. Geiker's recent publications demonstrate a strong emphasis on clinical nutrition research, with multiple randomized controlled trials and longitudinal studies examining dietary interventions during pregnancy, particularly for women with overweight or obesity. Her methodological expertise includes validation of dietary assessment tools and advanced body composition analysis using imaging techniques. She has secured research funding from diverse sources including the Novo Nordisk Foundation, Danish Pig Meat Association, Danish Dairy Research Foundation, Nordea Foundation, Arla Food for Health, and several other industry and charitable organizations focused on nutrition and health.

• Maternal and Child Health
• Women's Health
• Type 2 Diabetes
• +7 more

Dr. Kesha Baptiste-Roberts serves as Associate Professor and Chair of the Department of Public and Allied Health at Morgan State University's School of Community Health and Policy. She holds a PhD in Epidemiology from The Johns Hopkins Bloomberg School of Public Health, along with a Certificate in Maternal and Child Health from the same institution. Her academic journey also includes an MPH in Community Health-Epidemiology from Saint Louis University and a BS in Biology from Juniata College. Dr. Baptiste-Roberts' research spans multiple critical public health domains, with a strong emphasis on Maternal and Child Health. Her early work focused on pregnancy-related factors and their influence on cardiometabolic outcomes for both mother and offspring throughout the life course. More recently, she has directed her expertise toward improving maternal health for underserved communities through innovative approaches like telehealth and the doula model of care. Her scholarly contributions include over 30 publications and co-editing the book "Obesity in Pregnancy," demonstrating her commitment to addressing health disparities, particularly in women's health, type 2 diabetes, obesity, and racial/ethnic health inequities. 2021 Abraham Lilienfeld Award from the Epidemiology Section of the American Public Health Association (APHA) Principal Investigator of the Center for Maternal and Family Health funded by HRSA Health Research Network Leadership roles in the American Public Health Association (APHA) Leadership roles in the Society of the Analysis of African American Public Health Issues (SAAPHI) As an educator and researcher, Dr. Baptiste-Roberts has made significant contributions to understanding how socioeconomic factors, cultural beliefs, and healthcare access influence health outcomes. Her recent publications reflect a strategic shift toward addressing pandemic-related health challenges while maintaining her focus on maternal and child health disparities. Her work bridges epidemiological research with practical community health applications, particularly for underserved populations.

Byung ParkView profile

Professor

• Biostatistics
• Oncology Clinical Trials
• Immunology
• +2 more

Byung Park serves as Professor of Biostatistics at the OHSU-PSU School of Public Health, Director of the Biostatistics Shared Resource (BSR) at Knight Cancer Institute, and Associate Director of the Biostatistics and Bioinformatics Core (BBC) at Oregon National Primate Research Center. With continuous service since 2002, he provides critical statistical leadership for oncology and primate research initiatives across Oregon Health & Science University. His educational foundation includes: B.A. (1990) from Sung Kyun Kwan University M.S. (1992) from Sung Kyun Kwan University Ph.D. (2002) from Oregon State University Dr. Park specializes in oncology clinical trial design and immunology analysis, maintaining 20+ years of collaboration with Knight Cancer Institute and Oregon National Primate Research Center. His research integrates biostatistical methods with translational studies in cancer biomarkers, aging neuroscience, and perinatal health, particularly investigating maternal smoking effects and vitamin C interventions. This work frequently employs advanced longitudinal modeling and multi-omics integration. His publication record reveals consistent contributions to high-impact journals, with recent emphasis on pancreatic cancer biomarkers, primate aging models, and perinatal epigenetic mechanisms. Collaborative projects span statistical methodology development for complex clinical endpoints and biomarker validation in diverse disease contexts. His scientific recognition includes: Jerome Lee Award from Oregon State University (2002) AACR Cancer Biostatistics Workshop Scholarship (2008) As active reviewer for Knight Cancer Institute's Clinical Research Review Committee and Data Safety Monitoring Committee, Dr. Park ensures methodological rigor in clinical trials. He mentors junior biostatisticians through his leadership roles while developing statistical frameworks for grant-funded research across OHSU. The Biostatistics Shared Resource under his direction supports over 100 cancer research projects annually, while the BBC at ONPRC provides bioinformatics infrastructure for primate studies, creating synergies between statistical innovation and biological discovery.